Table 2

Prediction model coefficients*

ANCRC
Adjusted OR95% CIP valueAdjusted OR95% CIP value
Age†1.10.9 to 1.30.451.81.1 to 2.80.01
Male sex1.31.3 to 1.4<0.0011.21 to 1.40.05
First F-Hb concentration, µg Hb/g faeces
 0RefRef
 0.1–9.9‡2.82.6 to 3.1<0.0012.52.0 to 3.2<0.001
 10.0–19.94.23.7 to 4.7<0.0013.62.7 to 4.9<0.001
 20.0–29.95.74.8 to 6.7<0.0015.73.9 to 8.4<0.001
 30.0–39.96.65.4 to 8.0<0.0013.72.1 to 6.6<0.001
 40.0–46.99.47.5 to 11.7<0.0016.33.5 to 11.1<0.001
Second F-Hb concentration, µg Hb/g faeces
 0RefRef
 0.1–9.9‡4.84.3 to 5.3<0.0013.02.2 to 4.0<0.001
 10.0–19.96.25.5 to 7.0<0.0014.63.4 to 6.2<0.001
 20.0–29.97.96.8 to 9.1<0.0014.12.7 to 6.2<0.001
 30.0–39.98.06.7 to 9.5<0.0014.83.1 to 7.5<0.001
 40.0–46.98.67.0 to 10.5<0.0014.92.8 to 8.4<0.001
  • ORs were derived using logistic regression and examined using Wald tests.

  • *Coefficients are obtained as log (OR). The (exponentiated) model intercepts for advanced neoplasia and CRC were 0.005 (95% CI 0.005 to 0.006) and 0.001 (95% CI 0.001 to 0.001).

  • †OR for continuous age represents the estimated relative increase in the detection of AN or CRC for every 10-year increase in age.

  • ‡In multivariate analysis, positive F-Hb concentrations below the detection limit were combined in one category with concentrations just above that limit.

  • AN, advanced neoplasia; CRC, colorectal cancer ; F-Hb, faecal haemoglobin.